47 participants
CBP501, Cisplatin and Nivolumab in Advanced Refractory Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-03-10
- Start Date:
- 2017-10-25
- Completion:
- 2021-02-15
Conditions
- Advanced Solid Tumors
Interventions
- DRUG
No Results Yet